A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects
Status:
COMPLETED
Trial end date:
2025-01-20
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics in healthy subjects, and to evaluate the food effect on pharmacokinetics of HRS-2129.